Arcellx (ACLX) Amortizatization of Intangibles (2021 - 2025)
Arcellx's (ACLX) quarterly Amortizatization of Intangibles came in at $1.2 million in Q4 2025, down 65.13% year-on-year from $3.6 million in Q4 2024, and down 25.33% quarter-over-quarter from $1.7 million in Q3 2025.
Arcellx (ACLX) Amortizatization of Intangibles (2021 - 2025) Analysis & Trends
Arcellx's Amortizatization of Intangibles history runs 5 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- On a quarterly basis, Amortizatization of Intangibles fell 65.13% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $8.4 million, a 45.38% decrease from a year earlier, with the FY2025 full-year figure at $8.4 million, down 45.38% from the prior year.
- Amortizatization of Intangibles slipped to $1.2 million in Q4 2025 per ACLX's latest filing, from $1.7 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $4.4 million in Q1 2024 and bottomed at -$150000.0 in Q4 2021.
- The 5-year median for Amortizatization of Intangibles is $2.4 million (2025), against an average of $2.2 million.
- Across the five-year window, Amortizatization of Intangibles surged 3665.28% in 2023 and slumped 65.13% in 2025, its largest moves.
- Year by year, Amortizatization of Intangibles stood at -$150000.0 in 2021, then soared by 1004.67% to $1.4 million in 2022, then soared by 190.64% to $3.9 million in 2023, then retreated by 9.53% to $3.6 million in 2024, then plunged by 65.13% to $1.2 million in 2025.
- Per Business Quant, the three latest ACLX Amortizatization of Intangibles figures stand at $1.2 million (Q4 2025), $1.7 million (Q3 2025), and $2.4 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 1.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Sep 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Jun 30, 2025 | 2.40 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Mar 31, 2025 | 3.14 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Dec 31, 2024 | 3.57 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Sep 30, 2024 | 3.40 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Jun 30, 2024 | 4.13 Mn |
| Mar 31, 2024 | 4.36 Mn |
| Mar 31, 2024 | 4.36 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Dec 31, 2023 | 3.94 Mn |
| Sep 30, 2023 | 2.42 Mn |
| Sep 30, 2023 | 2.42 Mn |